A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: A promising path for progress emerges

被引：20
|
作者：
Sausville, EA [1 ]
机构：
[1] NCI, Dev Therapeut Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 02期
关键词：
D O I：
10.1093/jnci/91.2.102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [41] BCR-ABL TYROSINE KINASE DOMAIN MUTATIONS COMBINATIONS AFFECTS IMATINIB RESISTENCE IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
    Bintoro, S. U. Y.
    Amrita, P. N. A.
    Joewarini, E.
    Suryohusodo, P.
    Soebandiri, S.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (04): : 53 - 58
  • [42] Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia
    Holtick, Udo
    Marshall, Scoff R.
    O'Brien, Stephen G.
    Collin, Matthew P.
    BLOOD, 2007, 110 (13) : 4622 - 4623
  • [43] INDUCTION OF A CHRONIC MYELOGENOUS LEUKEMIA-LIKE SYNDROME IN MICE WITH V-ABL AND BCR/ABL
    KELLIHER, MA
    MCLAUGHLIN, J
    WITTE, ON
    ROSENBERG, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6649 - 6653
  • [44] Effect of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro
    Svingen, PA
    Tefferi, A
    Kottke, TJ
    Kaur, G
    Narayanan, VL
    Sausville, EA
    Kaufmann, SH
    CLINICAL CANCER RESEARCH, 2000, 6 (01) : 237 - 249
  • [45] Bcr/Abl tyrosine kinase recruits and phosphorylates β-catenin promoting its stabilization and nuclear signaling in Chronic Myelogenous Leukemia
    Coluccia, Addolorata M. L.
    Benati, Daniela
    Marchesi, Edoardo
    Vacca, Angelo
    Formelli, Franca
    Gambacorti-Passerini, Carlo
    CANCER RESEARCH, 2006, 66 (08)
  • [46] BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells
    Chu, S
    Holtz, M
    Gupta, M
    Bhatia, R
    BLOOD, 2004, 103 (08) : 3167 - 3174
  • [47] Transgenic mouse models of BCR/ABL-positive chronic myelogenous leukemia: A review
    Inokuchi, K
    CURRENT GENOMICS, 2005, 6 (02) : 89 - 95
  • [48] Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia
    Hai, Abdul
    Kizilbash, Nadeem A.
    Zaidi, Syeda Huma H.
    Alruwaili, Jamal
    Shahzad, Khuram
    BIOINFORMATION, 2014, 10 (03) : 108 - 114
  • [49] Frequency of BCR-ABL Fusion Transcripts in Saudi Patients with Chronic Myelogenous Leukemia
    Elbjeirami, W. M.
    Abdulwahab, A.
    Elsayed, H.
    Elnagdi, N.
    Abd Allatif, N.
    Al-Jedani, H.
    Al Shaikh, A.
    Al-Allaf, F. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 766 - 766
  • [50] BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
    Brauer, Katharina M.
    Werth, Daniela
    von Schwarzenberg, Karin
    Bringmann, Anita
    Kanz, Lothar
    Gruenebach, Frank
    Brossart, Peter
    BLOOD, 2006, 108 (11) : 624A - 625A
12345